| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/19/2011 | WO2011058994A1 Nonhuman animal model of type 2 diabetes |
| 05/19/2011 | WO2011058983A1 Hollow fiber membrane module for use in production of chemical substance, and process for production of chemical substance |
| 05/19/2011 | WO2011058767A1 Firefly luciferase and gene thereof, and process for production of firefly luciferase |
| 05/19/2011 | WO2011058765A1 Target gene for anti-cancer activity of tocotrienol, biomarker, and use of the biomarker |
| 05/19/2011 | WO2011058555A1 A method of editing dna in a cell and constructs capable of same |
| 05/19/2011 | WO2011058400A1 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses |
| 05/19/2011 | WO2011058364A1 Method of treatment and screening method |
| 05/19/2011 | WO2011058081A2 Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides |
| 05/19/2011 | WO2011058080A1 Anti-trypanosomiasis vaccines and diagnostics |
| 05/19/2011 | WO2011058055A1 Anti-trypanosome therapeutic and diagnostic applications |
| 05/19/2011 | WO2011058052A1 Direct protein delivery with engineered microvesicles |
| 05/19/2011 | WO2011058029A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/19/2011 | WO2011057825A1 Induction of gene expression in arthropods |
| 05/19/2011 | WO2011057487A1 Markers, methods, biochips and kits for milk qualit y detection |
| 05/19/2011 | WO2011057437A1 Anti-epidemic growth factor receptor antibody and encoding genes and uses thereof |
| 05/19/2011 | WO2011057436A1 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 05/19/2011 | WO2011057435A1 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 05/19/2011 | WO2011057397A1 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions |
| 05/19/2011 | WO2011057360A1 Recombinant antibody vector |
| 05/19/2011 | WO2011057350A1 Antisense molecules and methods for treating pathologies |
| 05/19/2011 | WO2011057333A1 Transgenic plant male sterility |
| 05/19/2011 | WO2011047233A8 Heating, shaking, and magnetizing apparatus and method of operating the same |
| 05/19/2011 | WO2011036569A3 Rice cultivar cl 142-ar |
| 05/19/2011 | WO2011034946A9 Generation of high polyhydroxybutrate producing oilseeds |
| 05/19/2011 | WO2011027966A3 Td probe and its uses |
| 05/19/2011 | WO2011024077A3 Exon skipping therapy for functional amelioration of semi functional dystrophin in becker and duchenne muscular dystrophy |
| 05/19/2011 | WO2011019793A3 Individualized therapy of single gene disorders with genetically modified adult stem cells |
| 05/19/2011 | WO2011017422A3 Methods and compositions relating to controlled induction of plant senescence |
| 05/19/2011 | WO2011011175A3 Method for sequencing a polynucleotide template |
| 05/19/2011 | WO2011008502A3 Isolation of unknown rearranged t-cell receptors from single cells |
| 05/19/2011 | WO2011007350A3 Use of nle proteins and tissue - targeted delivery system thereof for the treatment of imune-related disorders |
| 05/19/2011 | WO2011004994A3 A novel genome walking method for cloning of unknown dna sequences adjacent to known sequence |
| 05/19/2011 | WO2011002836A3 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto |
| 05/19/2011 | WO2011002237A3 Method for preparing genomic library derived from single cell of rare microorganisms or novel microorganisms based on dominant species removal technology |
| 05/19/2011 | WO2011002220A3 Preparation method of lactate polymers and lactate copolymers using polyhydroxyalkanoate synthase mutants |
| 05/19/2011 | WO2010148334A3 Generation of induced pluripotent stem cells from cord blood |
| 05/19/2011 | WO2010144602A3 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 05/19/2011 | WO2010124281A3 Selective detection of bordetella species |
| 05/19/2011 | WO2010118007A9 Enhanced cellulase expression in s. degradans |
| 05/19/2011 | WO2010110914A3 Mammalian genes involved in infection |
| 05/19/2011 | WO2010110599A3 Novel αlpha-neoagarobiose hydrolase, and method for obtaining a monosaccharide using same |
| 05/19/2011 | WO2010040526A8 Lcmv-gp-vsv-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors |
| 05/19/2011 | WO2006117782A3 Recombinant antibodies against cd55 and cd59 and uses thereof |
| 05/19/2011 | US20110119794 Rice non-endosperm tissue expression promoter (ostsp 1) and the use thereof |
| 05/19/2011 | US20110119792 Genes Controlling Plant Root Growth And Development For Stress Tolerance And Method Of Their Use |
| 05/19/2011 | US20110119791 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
| 05/19/2011 | US20110119789 Transcription factors for increasing yield |
| 05/19/2011 | US20110119788 Method for generating resistance against citrus diseases caused by insects, fungi, oomycetes, bacteria or nematodes |
| 05/19/2011 | US20110119787 Fructan biosynthetic enzymes |
| 05/19/2011 | US20110119786 Inositol polyphosphate 2-kinase genes and uses thereof |
| 05/19/2011 | US20110119784 Cotton Variety FM 1845LLB2 |
| 05/19/2011 | US20110119782 Construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences |
| 05/19/2011 | US20110119781 Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes |
| 05/19/2011 | US20110119779 Methods for sequential replacement of targeted region by homologous recombination |
| 05/19/2011 | US20110119778 Steganographic embedding of information in coding genes |
| 05/19/2011 | US20110118456 Interfering RNA Molecules |
| 05/19/2011 | US20110118445 Inhibitor protein of the wnt signal pathway |
| 05/19/2011 | US20110118444 Binding molecules |
| 05/19/2011 | US20110118433 Candida tropicalis cells and use thereof |
| 05/19/2011 | US20110118340 Delivery of rnai constructs to oligodendrocytes |
| 05/19/2011 | US20110118339 Chemically modified oligonucleotides and uses thereof |
| 05/19/2011 | US20110118338 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 05/19/2011 | US20110118335 RNA Interference Mediated Inhibition Of Gene Expression Using Multifunctional Short Interfering Nucleic Acid (Multifunctional siNA) |
| 05/19/2011 | US20110118333 Use on Minicircle vectors for cardiac gene therapy |
| 05/19/2011 | US20110118332 Viral microrna |
| 05/19/2011 | US20110118331 Cationic sirnas, synthesis and use for rna interference |
| 05/19/2011 | US20110118188 Factor viii polypeptide having factor viii:c activity |
| 05/19/2011 | US20110118181 Pcsk9 inhibitors and methods of use thereof |
| 05/19/2011 | US20110118150 Method for making biochips |
| 05/19/2011 | US20110118146 Phage Display Using Cotranslational Translocation of Fusion Polypeptides |
| 05/19/2011 | US20110118144 Engineered phage vectors for the design and the generation of a human non-antibody peptide or protein phage library via fusion to pix of m13 phage |
| 05/19/2011 | US20110118140 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| 05/19/2011 | US20110117655 Methods and compositions for genetically manipulating clostridia and related bacteria with homologous recombination associated proteins |
| 05/19/2011 | US20110117654 Buffer solution for electroporation and a method comprising the use of the same |
| 05/19/2011 | US20110117653 Method for production of pluripotent stem cell |
| 05/19/2011 | US20110117646 Antisense modulation of c-reactive protein expression |
| 05/19/2011 | US20110117644 DR5 gene promoter and SIAH-1 gene promoter |
| 05/19/2011 | US20110117643 Recombinant Expression Vector for Animal Cell |
| 05/19/2011 | US20110117642 Trap vectors and gene trapping method by using the same |
| 05/19/2011 | US20110117641 Plasmid DNA Isolation |
| 05/19/2011 | US20110117640 Tumor antigens bfa4 and bcy1 for prevention and / or treatment of cancer |
| 05/19/2011 | US20110117635 Multipurpose Micro Electric Field Network Cell Processing Device |
| 05/19/2011 | US20110117630 Method for Producing Extracellular Multi-Enzyme Complexes in Host Cells |
| 05/19/2011 | US20110117627 Regulation of apoptosis by neural specific splice variants of ig20 |
| 05/19/2011 | US20110117611 Nucleotide Sequences Which Code for the tal Gene |
| 05/19/2011 | US20110117610 Modified Dicer Polypeptide and Methods of Use Thereof |
| 05/19/2011 | US20110117609 Homologous Recombination Method, Cloning Method, and Kit |
| 05/19/2011 | US20110117608 Double-stranded nucleic acid |
| 05/19/2011 | US20110117602 Human antibody capable of inducing apoptosis |
| 05/19/2011 | US20110117600 Process for obtaining aspart insulin using a pichia pastoris yeast strain |
| 05/19/2011 | US20110117599 Artificial entropic bristle domain sequences and their use in recombinant protein production |
| 05/19/2011 | US20110117598 Enhanced Protein Production in Bacillus |
| 05/19/2011 | US20110117544 Method for producing an amplified polynucleotide sequence |
| 05/19/2011 | US20110117188 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 05/19/2011 | US20110117185 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions |
| 05/19/2011 | US20110117183 Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors |
| 05/19/2011 | US20110117138 Charge-dynamic polymers and delivery of anionic compounds |
| 05/19/2011 | US20110117132 Mutated salmonella typhi strain and use thereof in a vaccine |
| 05/19/2011 | US20110117131 Production of OspA for Lyme Disease Control |
| 05/19/2011 | US20110117124 Enhancement of transgene expression from viral-based vaccine vectors by expression of suppressors of the type i interferon response |